How Subcutaneous and Intramuscular Injections Are Shaping the Administration Route Landscape
The Italy Growth Hormone Deficiency market is expanding as healthcare providers invest in advanced therapeutic solutions to address the rising incidence of growth hormone deficiency and improve patient outcomes. The market was valued at USD 178.3 million in 2024 and is projected to reach USD 312.6 million by 2035, growing at a CAGR of 5.12%. The Italy Growth Hormone Deficiency Market includes...
0 Commentarios 0 Acciones 263 Views 0 Vista previa